USCB Financial (USCB) CEO exercises options and sells 10,005 shares

Rhea-AI Filing Summary

USCB Financial Holdings President and CEO Luis De La Aguilera exercised and sold a modest block of shares. He exercised stock options to acquire 10,005 shares of Class A Voting Common Stock at $11.35 per share, then sold 10,005 shares in open-market transactions at a weighted average price of $18.14 per share, with prices ranging from $18.10 to $18.20.

Following these transactions, he directly holds 242,945 shares of Class A Voting Common Stock and retains stock options over 160,000 shares of Common Stock with a $12.05 exercise price expiring on September 27, 2031. His position also includes multiple restricted stock grants that vest in thirds beginning between 2024 and 2027, indicating continued equity-based compensation alongside this routine exercise-and-sell activity.

Insights

Equity compensation and insider trading analyst

CEO executes routine option exercise-and-sell, retains sizable equity stake.

USCB Financial Holdings President and CEO Luis De La Aguilera exercised options for 10,005 shares at $11.35 and sold 10,005 shares at a weighted average of $18.14, with trade prices between $18.10 and $18.20. This pattern is typical of monetizing vested options.

After these trades, he still directly owns 242,945 shares and maintains options over 160,000 shares at a $12.05 exercise price expiring on September 27, 2031, plus unvested restricted stock grants. The sale represents a relatively small portion of his overall equity exposure, so this filing reads as routine liquidity rather than a major change in alignment.

Insider Trade Summary

Net Seller: 10,005 shares ($181,491)

Net Sell 4 txns

Insider DE LA AGUILERA LUIS

Role President and CEO

Sold 10,005 shs ($181K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	10,005	$0.00	--
Exercise	Class A Voting Common Stock	10,005	$11.35	$114K
Sale	Class A Voting Common Stock	10,005	$18.14	$181K
holding	Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct, null); Class A Voting Common Stock — 252,950 shares (Direct, null)

Footnotes (1)

1. Includes the grant of 27,632 shares of restricted stock which vest at a rate of one-third per year commencing on January 27, 2027, 17,102 shares of restricted stock from a grant of 25,653 shares which commenced vesting at a rate of one-third per year on January 21, 2026, 4,045 shares of restricted stock from a grant of 12,136 shares which commenced vesting at a rate of one-third per year on January 22, 2025, and 41,666 shares of restricted stock from a grant of 125,000 shares which commenced vesting at a rate of one-third per year on December 31, 2024. The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $18.10 to $18.20, inclusive. The reporting person undertakes to provide to USCB, or any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock options vested at the rate of one-third per year commencing on September 23, 2020. The stock options vested at the rate of one-third per year commencing on September 27, 2022.

Key Figures

Shares sold: 10,005 shares Weighted average sale price: $18.14 per share Option exercise price: $11.35 per share +4 more

7 metrics

Shares sold 10,005 shares Class A Voting Common Stock sold in open market

Weighted average sale price $18.14 per share Open-market sale, trades between $18.10 and $18.20

Option exercise price $11.35 per share Options exercised for 10,005 shares of Common Stock

Shares held after transaction 242,945 shares Class A Voting Common Stock directly owned post-transaction

Remaining option underlying shares 160,000 shares Stock options with $12.05 exercise price expiring 2031-09-27

Option exercise price (remaining grant) $12.05 per share Stock Option (Right to Buy) expiring 2031-09-27

Largest restricted stock grant mentioned 125,000 shares Grant with 41,666 shares remaining, vesting began 2024-12-31

Key Terms

Stock Option (Right to Buy), Class A Voting Common Stock, restricted stock, weighted price, +1 more

5 terms

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) with underlying 160,000 shares of Common Stock"

Class A Voting Common Stock financial

"Class A Voting Common Stock sold in open-market transactions"

restricted stock financial

"Includes the grant of 27,632 shares of restricted stock which vest at a rate of one-third per year"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

weighted price financial

"The price reported in column 4 is a weighted price"

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DE LA AGUILERA LUIS

(Last) (First) (Middle)

C/O USCB FINANCIAL HOLDINGS, INC.

2301 N.W. 87TH AVENUE

(Street)

DORAL FLORIDA 33172

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
USCB FINANCIAL HOLDINGS, INC. [ USCB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Voting Common Stock	05/07/2026		M		10,005	A	$11.35	252,950(1)	D
Class A Voting Common Stock	05/07/2026		S		10,005	D	$18.14(2)	242,945(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$11.35	05/07/2026		M			10,005	09/23/2020(3)	09/23/2029	Common Stock	10,005	$0	0	D
Stock Option (Right to Buy)	$12.05							09/27/2022(4)	09/27/2031	Common Stock	160,000		160,000	D

Explanation of Responses:

1. Includes the grant of 27,632 shares of restricted stock which vest at a rate of one-third per year commencing on January 27, 2027, 17,102 shares of restricted stock from a grant of 25,653 shares which commenced vesting at a rate of one-third per year on January 21, 2026, 4,045 shares of restricted stock from a grant of 12,136 shares which commenced vesting at a rate of one-third per year on January 22, 2025, and 41,666 shares of restricted stock from a grant of 125,000 shares which commenced vesting at a rate of one-third per year on December 31, 2024.

2. The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $18.10 to $18.20, inclusive. The reporting person undertakes to provide to USCB, or any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The stock options vested at the rate of one-third per year commencing on September 23, 2020.

4. The stock options vested at the rate of one-third per year commencing on September 27, 2022.

	/s/ Robert Anderson by P.O.A. for Luis de la Aguilera	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did USCB (USCB) report for its CEO?

USCB reported that President and CEO Luis De La Aguilera exercised options for 10,005 shares at $11.35 and sold 10,005 Class A Voting Common shares at a weighted average of $18.14 per share, in open-market trades within a narrow price range.

At what prices did the USCB CEO sell his 10,005 shares?

The shares were sold at a weighted average price of $18.14 per share. According to the disclosure, individual trades occurred between $18.10 and $18.20, and detailed breakdowns are available upon request from USCB or the Securities and Exchange Commission staff.

How many USCB shares does the CEO hold after this Form 4 transaction?

After the reported transactions, Luis De La Aguilera directly holds 242,945 shares of Class A Voting Common Stock. This figure reflects his remaining ownership following the 10,005-share option exercise and matching 10,005-share open-market sale disclosed in the Form 4 filing.

What stock options and equity awards does the USCB CEO still retain?

The CEO retains stock options over 160,000 shares of Common Stock with a $12.05 exercise price expiring on September 27, 2031. He also holds several restricted stock grants that vest in one-third increments beginning between 2024 and 2027, supporting ongoing equity-based compensation.

Is the USCB CEO’s Form 4 transaction mainly a sale or an exercise event?

The filing shows a combined exercise-and-sell event. Luis De La Aguilera exercised options for 10,005 shares at $11.35 and sold 10,005 shares in open-market transactions, while maintaining a significantly larger remaining shareholding and additional stock options and restricted stock awards.

How many USCB shares were sold versus exercised in this Form 4?

The CEO exercised options covering 10,005 shares of Common Stock and sold 10,005 Class A Voting Common shares. The one-for-one relationship between exercised and sold shares indicates he monetized this specific option block while keeping substantial overall equity exposure in USCB.